DEK and acute myeloid leukemia: Recently, the oncogene DEK has become a topic of intensive research; it was originally identified as one of the parts of the DEK-CAN fusion gene, arising from the translocation (6;9) (p23;q34), identified in patients with a subtype of acute myeloid leukemia [4].